Answers are grounded in this paper and cite their sources.
Daunorubicin may be a useful drug in inhibiting proliferative vitreoretinopathy after surgery for primary rhegmatogenous retinal detachment.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: